We are live on ! Find out more
RVLP

RVL Pharmaceuticals plc Ordinary Shares
RVLP

Delisted

RVLP was delisted on the 20th of October, 2023.

Back to rankings

66 hedge funds and large institutions have $41.1M invested in RVL Pharmaceuticals plc Ordinary Shares in 2020 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 26 increasing their positions, 16 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 16

61% more capital invested

Capital invested by funds: $25.6M → $41.1M (+$15.5M)

50% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 10

6% more funds holding

Funds holding: 62 → 66 (+4)

Holders
66
Holders Change
+4
Holders Change %
+6.45%
% of All Funds
1.35%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
15
Increased
26
Reduced
16
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DCM
DG Capital Management
New York
+$3.91M
2
BlackRock
BlackRock
New York
+$1.28M
3
GC
Globeflex Capital
California
+$481K
4
EP
Eversept Partners
New York
+$387K
5
JIC
Joel Isaacson & Co
New York
+$220K

Top Sellers

Rank Fund Capital Flow
1
SS
Sunbelt Securities
Texas
-$5.03M
2
SCM
Sio Capital Management
New York
-$1.83M
3
Millennium Management
Millennium Management
New York
-$1.33M
4
WCM
Wedge Capital Management
North Carolina
-$898K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$852K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$192K +$30.9K +6,312 +28%
First Trust Advisors
27
First Trust Advisors
Illinois
$191K +$12K +2,447 +9%
SS
28
Sunbelt Securities
Texas
$176K -$5.03M -1,027,777 -97%
Walleye Capital
29
Walleye Capital
New York
$173K +$126K +25,700 New
N
30
Nuveen
North Carolina
$154K +$112K +22,900 New
HW
31
Hancock Whitney
Mississippi
$151K +$110K +22,469 New
Morgan Stanley
32
Morgan Stanley
New York
$124K +$1.3K +265 +1%
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$121K +$27.3K +5,574 +45%
State of New Jersey Common Pension Fund D
34
State of New Jersey Common Pension Fund D
New Jersey
$113K – – –
RhumbLine Advisers
35
RhumbLine Advisers
Massachusetts
$109K +$15.6K +3,192 +24%
Dimensional Fund Advisors
36
Dimensional Fund Advisors
Texas
$109K +$79K +16,151 New
State of Wisconsin Investment Board
37
State of Wisconsin Investment Board
Wisconsin
$104K +$16.1K +3,300 +27%
Citadel Advisors
38
Citadel Advisors
Florida
$100K -$220K -44,943 -75%
Jacobs Levy Equity Management
39
Jacobs Levy Equity Management
New Jersey
$96K -$381K -77,915 -85%
New York State Common Retirement Fund
40
New York State Common Retirement Fund
New York
$92K – – –
Walleye Trading
41
Walleye Trading
New York
$84K +$61.2K +12,500 New
CSS
42
Cubist Systematic Strategies
Connecticut
$82K +$3.08K +629 +5%
Bank of America
43
Bank of America
North Carolina
$79K +$42.6K +8,707 +291%
HS
44
HighVista Strategies
Massachusetts
$79K +$57.7K +11,800 New
FDCDDQ
45
Federation des caisses Desjardins du Quebec
Quebec, Canada
$76.6K – – –
HSBC Holdings
46
HSBC Holdings
United Kingdom
$76K – – –
MAM
47
Meeder Asset Management
Ohio
$75K – – –
Wells Fargo
48
Wells Fargo
California
$74K -$2.18K -445 -4%
ProShare Advisors
49
ProShare Advisors
Maryland
$74K +$54K +11,034 New
AIG
50
American International Group
New York
$49K +$10.2K +2,094 +40%
1
2
3 4

RVLP Hedge Fund Activity: Q2 2020 in Review

66 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in RVL Pharmaceuticals plc Ordinary Shares (RVLP) for Q2 2020, worth a combined $41.1M — up 61% from $25.6M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new RVLP positions and 10 closed out — a net gain of 5 holders — while 26 added to existing stakes and 16 trimmed.

The largest buyer was DG Capital Management, opening a new position worth an estimated $3.91M. The largest seller was Sunbelt Securities, cutting an estimated $5.03M.

  • 66 institutional investors held RVL Pharmaceuticals plc Ordinary Shares (RVLP) as of Q2 2020, up from 62 in Q1 2020.
  • Funds reported $41.1M of RVL Pharmaceuticals plc Ordinary Shares stock for Q2 2020, up 61% quarter-over-quarter.
  • 15 funds opened new RVL Pharmaceuticals plc Ordinary Shares positions in Q2 2020 and 10 closed out, a net change of +5 holders.
  • The largest RVL Pharmaceuticals plc Ordinary Shares buyer in Q2 2020 was DG Capital Management, an estimated $3.91M added.
  • The largest RVL Pharmaceuticals plc Ordinary Shares seller in Q2 2020 was Sunbelt Securities, an estimated $5.03M sold.

Based on aggregated 13F filings for Q2 2020.